Navigation Links
Combination Therapy to the Rescue off Lung Cancer Patients

A Combination of thermal ablation and radiation therapy, when used to treat patients who are in the early stages of inoperable lung cancer, increases chances of survival//, say researchers at Rhode Island Hospital.

In a retrospective study looking at patients over seven years, the median survival rate at three years increased from 20 months after radiation alone to 42 months when thermal ablation was followed by radiation for treatment of non-small-cell lung cancer. The results are published in the July issue of the Journal of Vascular and Interventional Radiology.

"This study shows us that even patients who are not eligible for surgery can still get very good results," says senior author Damian Dupuy, MD, director of ultrasound at Rhode Island Hospital and professor of diagnostic imaging at Brown Medical School, both in Providence, RI. "By combining thermal ablation and radiation, you have a better chance of survival than with either treatment alone."

With radiation alone, overall survival rates were as follows:
one year – 57 percent
two years – 36 percent
three years – 21 percent

With thermal ablation and radiation, they were significantly higher:
one year – 87 percent
two years – 70 percent
three years – 57 percent

Surgery is the standard treatment for lung cancer. However, only one-third of patients with early stage lung cancer qualify for surgery because of other underlying medical conditions. Radiation therapy has long been used for inoperable lung cancer, and more recently, doctors have used radio frequency ablation (RFA) and microwave ablation, processes that heat tumors to destroy them. For patients who cannot have surgery or radiation, the median survival is about one year.

In this study, researchers looked retrospectively at 41 patients treated over seven years with thermal ablation (RFA or microwave ablation) and either standard radiation therapy or brachytherapy
'"/>




Page: 1 2 3

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...ving food supplements to improve their behaviour a...the go-ahead. Currently, it is still investigating...n Hill said the South Australian Health Department... claimed that children as young as five would bene...
...i Ramadoss Wednesday assured representatives of th...lling //to bring amendments in the legislation con...overnment is willing to bring further amendments i...ostic Techniques (Prohibition of Sex Selection) Ac...
...he Palestinian territory following the recent cut-...gency has called for urgent action by the internat...ical services. "The crisis is seriously affecting ...y of Health to deliver critical health care servic...
...ve approval from the USFDA to market Pravastatin S...approval was given for strengths of 10 mg, 20 mg, ...tock Exchange. The company would market the drug t...dus Pharmaceuticals (USA) Inc, following patent ex...
Other Medicine News:
(Date:8/19/2008)...e samples to be used to identify molecular,signatu.... 19 /PRNewswire-USNewswire/ -- ALS Therapy,Develo...leration of an ALS,biomarker effort using blood sa...nical partnerships. These ongoing projects are par... the altered expression of genes,and proteins, at ...
(Date:8/19/2008)...Newswire-FirstCall/ -- Vical Incorporated,(Nasdaq:...with the Karolinska,Institute, a leading European ...Infectious Disease Control (SMI), a governmental e...uvant with the Biojector(R) 2000,needle-free injec...CBB:BJCT) for a multivalent preventive DNA vaccine...
(Date:8/18/2008)...Newswire/ -- The next time you consider popping a,...e worth counting sheep,instead. A senior psychiatr...o, Calif. has found evidence that taking sleeping ...er., Daniel F. Kripke, M.D.,s article, based on a...nd cancer, has just been published in the Journal,...
(Date:8/18/2008)...ope for increased life expectancy for people with,...Newswire/ -- In the world of Down,syndrome, ,Mr. C...en,tracked for the past 16 years, at seventy, ,Mr.... of a person with Down syndrome, currently in the,...rn. Further, ,Mr. C, does,not exhibit clinical sym...
Breaking Medicine Technology:ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Prescription Sleeping Pill Use Tied to Cancer 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3MITs McGovern Institute honors Emory neuroscientist for contributions to psychiatry 11391 1MITs McGovern Institute honors Emory neuroscientist for contributions to psychiatry 11391 2Hillenbrand Industries Announces Second Quarter 2008 Dividend 11389 1BioMS Medical to present at BIO CEO 26 Investor Conference 3142 1BioMS Medical to present at BIO CEO 26 Investor Conference 3142 2Tom Shaws NFL Training Center Chooses SURGEX 28TM 29 as Their Exclusive Post Training Nutritional Regimen 3141 1Tom Shaws NFL Training Center Chooses SURGEX 28TM 29 as Their Exclusive Post Training Nutritional Regimen 3141 2Tom Shaws NFL Training Center Chooses SURGEX 28TM 29 as Their Exclusive Post Training Nutritional Regimen 3141 3
...eved both primary and secondary endpoints of,study...etween,valopicitabine and ribavirin ~, CAMBRIDGE, ...nix,Pharmaceuticals, Inc. today announced results ...combination therapy, consisting of,valopicitabine ...tment of hepatitis C, pegylated interferon and rib...
...BUSINESS WIRE)--Jun 12, 2007 - Geron,Corporation,s...RN163L, has demonstrated good pharmacokinetics and...lving patients with chronic,lymphocytic leukemia (...lowick, M.D., M.P.H., the company,s president, onc...aui, Hawaii., Favorable Pharmacokinetics; Pharmaco...
Other Medicine Technology:Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 2Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 3Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 4
Antelys Peek Lumbar Technologies provides a range of varied heights and angles to correct lumbar lordosis and the associated sagital balance.
Spectrum Dynamics empowers Nuclear Imaging with the SmartR Technology,of the D-SPECT Cardiac Imaging System. The D-SPECT is powered by BroadView Technology to provide unprecedented throughput, whil
For immediate disabling
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface.
Medicine Products: